August 14, 2025

Antidepressants May Benefit IBD Through Shared Mechanisms

Researchers examine how inflammatory bowel disease and depression share biological mechanisms and how treating one may improve outcomes in the other.

Conexiant

August 14, 2025

Who Benefits From Vaccine Misinformation?

US vaccination rates have declined in recent years, coinciding with increased public debate over vaccine safety and policy.

KFF Health News

August 13, 2025

Dressed for Trust: What Patients See

Research reveals how physician attire influences trust, professionalism, and patient connection — and why context is everything.

Conexiant

August 12, 2025

Advanced-Practice Providers Filling Rural ER Gaps

Rural emergency rooms across the U.S. are increasingly staffed by physician assistants and nurse practitioners instead of physicians, raising debates over care quality, staffing shortages, and access to emergency services.

KFF Health News

August 11, 2025

Ustekinumab Outperforms Vedolizumab in Pouch Crohn’s Disease

Researchers compare long-term outcomes of two biologics in managing Crohn’s disease of the pouch, focusing on clinical response, remission rates, and adverse event profiles in a real-world multicenter setting.

Conexiant

August 08, 2025

Oral Surgeon Settles Over 500K in Billing Fraud Case

The state says the dentist upcoded and double-billed over 3-year period.

Conexiant

August 08, 2025

Unprompted Speech Changes Found in ME/CFS

Nearly 1 in 10 individuals with myalgic encephalomyelitis/chronic fatigue syndrome reported voice or speech changes in a recent survey, despite not being directly asked about these symptoms.

Conexiant

August 07, 2025

Flu Treatment Linked to Lower Neuropsychiatric Risk in Pediatric and Adolescent Patients

Subgroup analyses demonstrated a greater reduction in neurologic events than psychiatric events, though the reduction in psychiatric events was not statistically significant.

Conexiant

August 07, 2025

Allogeneic Islet Transplant Shows Promise Without Immunosuppression

First-in-human trial shows genetically engineered islet cells restore insulin secretion in type 1 diabetes without triggering immune rejection.

Conexiant